Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aya Kato

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
In Vivo (Athens, Greece)|April 30, 2024
The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Journal of Surgical Oncology|September 27, 2023
Short- and long-term outcomes of transanal decompression tube and self-expandable metallic stent for obstructive colorectal cancer based on a multicenter database (KYCC2110)Koji Numata, Masakatsu Numata, Junya Shirai, et al.
Anticancer Research|December 30, 2023
Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative TreatmentToru Aoyama, Aya Kato, Yukio Maezawa, et al.
Anticancer Research|December 30, 2023
Geriatric Nutritional Risk Index Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative TreatmentAya Kato, Toru Aoyama, Yukio Maezawa, et al.
The Tohoku Journal of Experimental Medicine|August 28, 2015
CRP 1846C>T Genetic Polymorphism Is Associated with Lymph Node Metastasis and/or Severe Lymphatic Invasion in Endometrial CancerMasahiko Kito, Satoru Motoyama, Kazuma Fujita, et al.
Anticancer Research|March 29, 2022
A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)Aya Kato, Norikatsu Miyoshi, Toru Ohtsuru, et al.
Anticancer Research|December 30, 2023
Clinical Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgical Patients With Pancreatic CancerShinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Surgical Case Reports|February 15, 2024
Non-invasive intraductal oncocytic papillary neoplasm forming a protruding lesion toward the duodenum from the accessory papilla: a case reportShinnosuke Kawahara, Naoto Yamamoto, Kota Washimi, et al.
In Vivo (Athens, Greece)|August 31, 2023
Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal CancerHiroshi Tamagawa, Ayako Tamagawa, Toru Aoyama, et al.
In Vivo (Athens, Greece)|February 28, 2024
Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative TreatmentMomoko Fukuda, Toru Aoyama, Itaru Hashimoto, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
In Vivo (Athens, Greece)|April 30, 2024
The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Journal of Surgical Oncology|September 27, 2023
Short- and long-term outcomes of transanal decompression tube and self-expandable metallic stent for obstructive colorectal cancer based on a multicenter database (KYCC2110)Koji Numata, Masakatsu Numata, Junya Shirai, et al.
Anticancer Research|December 30, 2023
Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative TreatmentToru Aoyama, Aya Kato, Yukio Maezawa, et al.
Anticancer Research|December 30, 2023
Geriatric Nutritional Risk Index Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative TreatmentAya Kato, Toru Aoyama, Yukio Maezawa, et al.
The Tohoku Journal of Experimental Medicine|August 28, 2015
CRP 1846C>T Genetic Polymorphism Is Associated with Lymph Node Metastasis and/or Severe Lymphatic Invasion in Endometrial CancerMasahiko Kito, Satoru Motoyama, Kazuma Fujita, et al.
Anticancer Research|March 29, 2022
A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)Aya Kato, Norikatsu Miyoshi, Toru Ohtsuru, et al.
Anticancer Research|December 30, 2023
Clinical Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgical Patients With Pancreatic CancerShinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Surgical Case Reports|February 15, 2024
Non-invasive intraductal oncocytic papillary neoplasm forming a protruding lesion toward the duodenum from the accessory papilla: a case reportShinnosuke Kawahara, Naoto Yamamoto, Kota Washimi, et al.
In Vivo (Athens, Greece)|August 31, 2023
Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal CancerHiroshi Tamagawa, Ayako Tamagawa, Toru Aoyama, et al.
In Vivo (Athens, Greece)|February 28, 2024
Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative TreatmentMomoko Fukuda, Toru Aoyama, Itaru Hashimoto, et al.
Pageof 9